High-dose melatonin does not show survival benefit for patients with solid tumours metastatic to the brain who were receiving whole-brain radiotherapy Journal Article

  

Authors:	Wesa, K.; Cassileth, B.
Article Title:	High-dose melatonin does not show survival benefit for patients with solid tumours metastatic to the brain who were receiving whole-brain radiotherapy
Keywords:	cancer survival; clinical trial; solid tumor; cancer radiotherapy; brain radiation; drug megadose; outcome assessment; survival time; evening dosage; morning dosage; brain metastasis; short survey; melatonin
Journal Title:	Focus on Alternative and Complementary Therapies
Volume:	13
Issue:	1
ISSN:	1465-3753
Publisher:	John Wiley & Sons
Date Published:	2008-03-01
Start Page:	28
End Page:	29
Language:	English
PROVIDER:	scopus
DOI:	10.1211/fact.13.1.0013
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-40149112015&partnerID=40&md5=31895c2572e43c513fb411e95b5285e5
Notes:	--- - "Export Date: 17 November 2011" - "CODEN: FACTC" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/15591